Furthermore, the Rho-associated kinase (ROCK) inhibitor Y-27632, which was conformed to decrease phospho-cofilin by immunoblot, suppressed the migration rate of thyroid cancer cells treated with TSH in the absent of FBS. The gene discussed is CFL1; the disease is thyroid cancer.